Addus HomeCare (NASDAQ:ADUS) Stock Price Target Raised at Barclays

Addus HomeCare (NASDAQ:ADUS) had its price objective upped by Barclays from $96.00 to $101.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has an underweight rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. Bank of America cut shares of Addus HomeCare from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $140.00 to $125.00 in a research note on Monday, September 14th. Citigroup cut shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. Raymond James Financial set a $137.00 price target on shares of Addus HomeCare in a research note on Monday, September 28th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. Finally, Royal Bank Of Canada boosted their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $128.62.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $127.94 on Wednesday. Addus HomeCare has a 52 week low of $87.95 and a 52 week high of $130.40. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $2.39 billion, a PE ratio of 21.32, a price-to-earnings-growth ratio of 1.80 and a beta of 0.75. The stock’s 50-day moving average price is $117.35 and its 200-day moving average price is $106.71.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.37%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.56 EPS. As a group, equities analysts expect that Addus HomeCare will post 6.33 EPS for the current fiscal year.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ADUS. Nisa Investment Advisors LLC boosted its holdings in Addus HomeCare by 16.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after purchasing an additional 111 shares during the last quarter. Assenagon Asset Management S.A. grew its stake in shares of Addus HomeCare by 2.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company’s stock valued at $593,000 after buying an additional 114 shares during the period. Janney Montgomery Scott LLC increased its holdings in shares of Addus HomeCare by 1.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 12,254 shares of the company’s stock worth $1,148,000 after buying an additional 132 shares during the last quarter. Net Worth Advisory Group raised its position in shares of Addus HomeCare by 4.1% during the 3rd quarter. Net Worth Advisory Group now owns 3,419 shares of the company’s stock valued at $382,000 after buying an additional 136 shares during the period. Finally, Hohimer Wealth Management LLC raised its position in shares of Addus HomeCare by 5.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 2,809 shares of the company’s stock valued at $311,000 after buying an additional 143 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: ADUS reported adjusted earnings of $1.83 per share, above the roughly $1.79 consensus estimate and up from $1.56 a year earlier. Revenue grew 7% year over year to $387.74 million, supporting the view of continued growth. Addus HomeCare Q3 earnings results
• Positive Sentiment: A post-earnings analysis highlighted steady organic growth and the AccentCare acquisition as a potential platform for further expansion, adding to the longer-term growth case. ADUS Q3 2026 deep dive
• Negative Sentiment: Barclays raised its price target to $101 from $96 but maintained an “underweight” rating. The new target remains well below the reported share price, signaling continued valuation concerns from the analyst. Barclays stock recommendations
• Neutral Sentiment: Revenue came in slightly below analysts’ estimate of $388.72 million, making the quarter’s performance less uniformly positive than the EPS beat. Addus HomeCare Q3 results

About Addus HomeCare

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.